CAH
Profit’s up, and management is feeling spicy
Cardinal Health kicked out its Q4 numbers and the headline was pretty simple: profit climbed hard, helped by revenue strength. That’s the kind of report that tells investors the engine is still humming, not sputtering.
The real kicker: FY27
The company didn’t stop at the rearview mirror. It also laid out a fiscal 2027 outlook and said it expects higher adjusted earnings. Translation: management is signaling this isn’t just a one-quarter sugar high.
Then came the buyback bonanza
Cardinal Health also approved a fresh $5 billion share repurchase plan. That matters because buybacks can boost earnings per share and usually tell you the company thinks its stock is worth supporting with real cash, not just nice words.
Why should you care? Because this is the classic investor cocktail:
- stronger current profits
- a better-looking long-term roadmap
- fewer shares in the market if the buyback gets rolling
Big picture: Cardinal Health is basically saying, “We’re not done growing, and we’d like a bigger slice of that growth to come back to shareholders.”